摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(1,3-苯并二氧戊环-5-基)-6-氟-3-羟基-4H-苯并吡喃-4-酮 | 4257-54-9

中文名称
2-(1,3-苯并二氧戊环-5-基)-6-氟-3-羟基-4H-苯并吡喃-4-酮
中文别名
——
英文名称
2-(benzo[d][1,3]dioxol-5-yl)-6-fluoro-3-hydroxy-4H-chromen-4-one
英文别名
6-Fluor-3'.4'-methylendioxy-flavonol;2-benzo[1,3]dioxol-5-yl-6-fluoro-3-hydroxy-chromen-4-one;2-(1,3-Benzodioxol-5-yl-6-Fluoro-3-Hydroxy-4H-Chromen-4-One;2-(1,3-benzodioxol-5-yl)-6-fluoro-3-hydroxychromen-4-one
2-(1,3-苯并二氧戊环-5-基)-6-氟-3-羟基-4H-苯并吡喃-4-酮化学式
CAS
4257-54-9
化学式
C16H9FO5
mdl
——
分子量
300.243
InChiKey
HOOKBINPTRTSKO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    116 °C
  • 沸点:
    462.2±45.0 °C(Predicted)
  • 密度:
    1.583±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    22
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    65
  • 氢给体数:
    1
  • 氢受体数:
    6

反应信息

  • 作为产物:
    描述:
    3-(Benzo[1,3]dioxol-5-yl)-1-(5-fluoro-2-hydroxyphenyl)-2-propen-1-one 在 双氧水 、 sodium hydroxide 作用下, 以 乙醇 为溶剂, 以52%的产率得到2-(1,3-苯并二氧戊环-5-基)-6-氟-3-羟基-4H-苯并吡喃-4-酮
    参考文献:
    名称:
    SAR Studies and Biological Characterization of a Chromen-4-one Derivative as an Anti-Trypanosoma brucei Agent
    摘要:
    Chemical modulation of the flavonol 2-(benzo[d] [1,3]dioxo1-5-y1)-chromen-4-one (1), a promising anti-Trypanosomatid agent previously identified, was evaluated through a phenotypic screening approach. Herein, we have performed structure activity relationship studies around hit compound 1. The pivaloyl derivative (13) showed significant anti-T. brucei activity (EC50 = 1.1 1iM) together with a selectivity index higher than 92. The early in vitro ADME-tox properties (cytotoxicity, mitochondria] toxicity, cytochrome P450 and hERG inhibition) were determined for compound 1 and its derivatives, and these led to the identification of some liabilities. The 1,3-benzodioxole moiety in the presented compounds confers better in vivo pharmacokinetic properties than those of classical flavonols. Further studies using different delivery systems could lead to an increase of compound blood levels.
    DOI:
    10.1021/acsmedchemlett.8b00565
点击查看最新优质反应信息

文献信息

  • NOVEL CDK INHIBITORS HAVING FLAVONE STRUCTURE
    申请人:LG CHEMICAL LIMITED
    公开号:EP1109800A1
    公开(公告)日:2001-06-27
  • US6500846B1
    申请人:——
    公开号:US6500846B1
    公开(公告)日:2002-12-31
  • [EN] NOVEL CDK INHIBITORS HAVING FLAVONE STRUCTURE<br/>[FR] NOUVEAUX INHIBITEURS DE KINASE DEPENDANTE DES CYCLINES (CDK) PRESENTANT UNE STRUCTURE FLAVONE
    申请人:LG CHEMICAL LTD
    公开号:WO2000012496A1
    公开(公告)日:2000-03-09
    The present invention relates to a novel flavone derivative, pharmaceutically acceptable salt, hydrate, solvate and isomer thereof which is useful as an inhibitor against Cyclin Dependent Kinase (CDK), a process for preparation thereof, and a composition of anti-cancer agent or agent for treating neurodegenerative disease comprising this compound as an active ingredient.
查看更多